Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer

This study evaluated outcomes associated with a high-dose-rate (HDR) brachytherapy boost combined with stereotactic body radiation therapy (SBRT) for patients with higher-risk localized prostate cancer.

Source: Brachytherapy - September 26, 2021 Category: Cancer & Oncology Authors: Daniel Gorovets, Margaret Hopkins, Marisa Kollmeier, Assaf Moore, Arun Goel, Daniel Shasha, Victoria Brennan, Sean McBride, Gilad Cohen, Antonio L. Damato, Michael J. Zelefsky Source Type: research